Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Net Cash Flow: 2011-2025

Historic Net Cash Flow for Sonoma Pharmaceuticals (SNOA) over the last 14 years, with Mar 2025 value amounting to $2.9 million.

  • Sonoma Pharmaceuticals' Net Cash Flow rose 181.28% to $1.3 million in Q1 2013 from the same period last year, while for Mar 2013 it was $4.5 million, marking a year-over-year increase of 580.38%. This contributed to the annual value of $2.9 million for FY2025, which is 495.30% up from last year.
  • According to the latest figures from FY2025, Sonoma Pharmaceuticals' Net Cash Flow is $2.9 million, which was up 495.30% from -$724,000 recorded in FY2024.
  • Sonoma Pharmaceuticals' Net Cash Flow's 5-year high stood at $3.0 million during FY2022, with a 5-year trough of -$3.9 million in FY2023.
  • Over the past 3 years, Sonoma Pharmaceuticals' median Net Cash Flow value was -$724,000 (recorded in 2024), while the average stood at -$594,333.
  • Per our database at Business Quant, Sonoma Pharmaceuticals' Net Cash Flow soared by 858.81% in 2022 and then plummeted by 228.60% in 2023.
  • Sonoma Pharmaceuticals' Net Cash Flow (MRY) stood at $318,000 in 2021, then skyrocketed by 858.81% to $3.0 million in 2022, then tumbled by 228.60% to -$3.9 million in 2023, then skyrocketed by 81.54% to -$724,000 in 2024, then surged by 495.30% to $2.9 million in 2025.
  • Its last three reported values are $2.9 million in FY2025, -$724,000 for FY2024, and -$3.9 million during FY2023.